Drug Design, Development and Therapy

Advances in design and development of ophthalmic drugs

Ophthalmic diseases, including glaucoma, age-related macular degeneration, diabetic retinopathy, and dry eye disease, are a significant public health concern, affecting millions of people worldwide. Despite the increasing availability of some effective treatments, there is still an unmet need for safe and even more effective drugs that can treat these conditions. This Article Collection brings together leading researchers and clinicians in the field to present their latest research on the design and development of ophthalmic drugs.